IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

Isocitrate dehydrogenase (IDH) enzymes catalyse the oxidative decarboxylation of isocitrate and therefore play key roles in the Krebs cycle and cellular homoeostasis. Major advances in cancer genetics over the past decade have revealed that the genes encoding IDHs are frequently mutated in a variety...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of cancer Ročník 122; číslo 11; s. 1580 - 1589
Hlavní autori:	Han, Sue, Liu, Yang, Cai, Sabrina J., Qian, Mingyu, Ding, Jianyi, Larion, Mioara, Gilbert, Mark R., Yang, Chunzhang
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 26.05.2020 Nature Publishing Group
Predmet:	631/208/737 631/80 Acute myeloid leukemia Animals Biomedical and Life Sciences Biomedicine Brain Neoplasms - genetics Cancer Research Cell Transformation, Neoplastic - genetics Cholangiocarcinoma Chondrosarcoma Decarboxylation Drug Resistance Epidemiology Glioma Glioma - genetics Humans Isocitrate dehydrogenase Isocitrate Dehydrogenase - genetics Leukemia Molecular Medicine Molecular modelling Mutants Mutation Oncology Review Review Article Therapeutic applications Thyroid cancer Thyroid carcinoma Tricarboxylic acid cycle Tumorigenesis
ISSN:	0007-0920, 1532-1827, 1532-1827
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!